Table 2.
DCIS (N = 202) | Invasive component (N = 15) | p | |
---|---|---|---|
MRI tumor size | 0.172 | ||
≤ 2 cm | 99 (49.0%) | 6 (40.0%) | |
> 2 cm | 101 (50.0%) | 8 (53.3%) | |
Not seen | 2 (1.0%) | 1 (6.7%) | |
Nipple-areolar complex invasion | 1.000 | ||
Absent | 191 (94.6%) | 14 (93.3%) | |
Present | 11 (5.4%) | 1 (6.7%) | |
Enlarged lymph node | 0.612 | ||
Absent | 166 (82.2%) | 11 (73.3%) | |
Present | 36 (17.8%) | 4 (26.7%) | |
MRI NME | 0.002 | ||
Mass | 102 (50.5%) | 12 (80.0%) | |
NME | 100 (49.5%) | 3 (20.0%) | |
Enhancement peak | 0.649 | ||
≤ 100% | 37 (18.3%) | 4 (26.7%) | |
> 100% | 165 (81.7%) | 11 (73.3%) | |
Initial enhancement pattern of dynamic curve | 0.735 | ||
Rapid | 162 (80.2%) | 11 (73.3%) | |
Medium | 26 (12.9%) | 3 (20.0%) | |
Slow | 14 (6.9%) | 1 (6.7%) | |
Kinetic pattern | 0.253 | ||
Persistent | 68 (33.7%) | 4 (26.7%) | |
Plateau | 68 (33.7%) | 3 (20.0%) | |
Washout | 66 (32.7%) | 8 (53.3%) |
Data are expressed as n (%)
Abbreviations DCIS Ductal carcinoma in situ, US Ultrasonography, NME Non-mass enhancement